Literature DB >> 24256622

Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.

Lourena E Costa1, Mayara I S Lima, Miguel A Chávez-Fumagalli, Daniel Menezes-Souza, Vivian T Martins, Mariana C Duarte, Paula S Lage, Eliane G P Lopes, Daniela P Lage, Tatiana G Ribeiro, Pedro H R Andrade, Danielle F de Magalhães-Soares, Manuel Soto, Carlos A P Tavares, Luiz R Goulart, Eduardo A F Coelho.   

Abstract

Visceral leishmaniasis (VL) is a zoonotic disease that is endemic to Brazil, where dogs are the main domestic parasite reservoirs, and the percentages of infected dogs living in regions where canine VL (CVL) is endemic have ranged from 10% to 62%. Despite technological advances, some problems have been reported with CVL serodiagnosis. The present study describes a sequential subtractive selection through phage display technology from polyclonal antibodies of negative and positive sera that resulted in the identification of potential bacteriophage-fused peptides that were highly sensitive and specific to antibodies of CVL. A negative selection was performed in which phage clones were adhered to purified IgGs from healthy and Trypanosoma cruzi-infected dogs to eliminate cross-reactive phages. The remaining supernatant nonadhered phages were submitted to positive selection against IgG from the blood serum of dogs that were infected with Leishmania infantum. Phage clones that adhered to purified IgGs from the CVL-infected serum samples were selected. Eighteen clones were identified and their reactivities tested by a phage enzyme-linked immunosorbent assay (phage-ELISA) against the serum samples from infected dogs (n = 31) compared to those from vaccinated dogs (n = 21), experimentally infected dogs with cross-reactive parasites (n = 23), and healthy controls (n = 17). Eight clones presented sensitivity, specificity, and positive and negative predictive values of 100%, and they showed no cross-reactivity with T. cruzi- or Ehrlichia canis-infected dogs or with dogs vaccinated with two different commercial CVL vaccines in Brazil. Our study identified eight mimotopes of L. infantum antigens with 100% accuracy for CVL serodiagnosis. The use of these mimotopes by phage-ELISA proved to be an excellent assay that was reproducible, simple, fast, and inexpensive, and it can be applied in CVL-monitoring programs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24256622      PMCID: PMC3910914          DOI: 10.1128/CVI.00583-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  62 in total

1.  Structure of a malaria parasite antigenic determinant displayed on filamentous bacteriophage determined by NMR spectroscopy: implications for the structure of continuous peptide epitopes of proteins.

Authors:  M Monette; S J Opella; J Greenwood; A E Willis; R N Perham
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

Review 2.  Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics.

Authors:  Lin-Fa Wang; Meng Yu
Journal:  Curr Drug Targets       Date:  2004-01       Impact factor: 3.465

3.  The diagnostic odds ratio: a single indicator of test performance.

Authors:  Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt
Journal:  J Clin Epidemiol       Date:  2003-11       Impact factor: 6.437

4.  Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens.

Authors:  J Greenwood; A E Willis; R N Perham
Journal:  J Mol Biol       Date:  1991-08-20       Impact factor: 5.469

5.  Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission.

Authors:  Orin Courtenay; Rupert J Quinnell; Lourdes M Garcez; Jeffrey J Shaw; Christopher Dye
Journal:  J Infect Dis       Date:  2002-10-11       Impact factor: 5.226

6.  Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes.

Authors:  R Roccasecca; A Folgori; B B Ercole; G Puntoriero; A Lahm; S Zucchelli; R Tafi; M Pezzanera; G Galfre; A Tramontano; M U Mondelli; A Pessi; A Nicosia; R Cortese; A Meola
Journal:  Mol Immunol       Date:  2001-12       Impact factor: 4.407

7.  Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.

Authors:  Cláudia Martins Carneiro; Olindo Assis Martins-Filho; Alexandre Barbosa Reis; Vanja Maria Veloso; Flávio Marcos Gomes Araújo; Maria Terezinha Bahia; Marta de Lana; George Luiz Lins Machado-Coelho; Giovanni Gazzinelli; Rodrigo Correa-Oliveira; Washington Luiz Tafuri
Journal:  Acta Trop       Date:  2007-01-10       Impact factor: 3.112

8.  Evaluation of serological cross-reactivity between canine visceral leishmaniasis and natural infection by Trypanosoma caninum.

Authors:  A S Alves; E Mouta-Confort; F B Figueiredo; R V C Oliveira; A O Schubach; M F Madeira
Journal:  Res Vet Sci       Date:  2012-07-27       Impact factor: 2.534

9.  Screening of horse polyclonal antibodies with a random peptide library displayed on phage: identification of ligands used as antigens in an ELISA test to detect the presence of antibodies to equine arteritis virus.

Authors:  P Iniguez; S Zientara; M Marault; I B Machin; D Hannant; C Cruciere
Journal:  J Virol Methods       Date:  1998-08       Impact factor: 2.014

10.  Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries.

Authors:  Elisa Beghetto; Andrea Spadoni; Wilma Buffolano; Mariassunta Del Pezzo; Olga Minenkova; Emiliano Pavoni; Andrea Pucci; Riccardo Cortese; Franco Felici; Nicola Gargano
Journal:  Int J Parasitol       Date:  2003-02       Impact factor: 3.981

View more
  9 in total

1.  Serological diagnosis of Mycoplasma pneumoniae infection by using the mimic epitopes.

Authors:  Wenyuan Shi; Lanhua Zhao; Shengtao Li; Guizhen Xu; Yanhua Zeng
Journal:  World J Microbiol Biotechnol       Date:  2018-05-29       Impact factor: 3.312

Review 2.  A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.

Authors:  Daniela P Lage; Vívian T Martins; Mariana C Duarte; Lourena E Costa; Esther Garde; Laura M Dimer; Amanda C S Kursancew; Miguel A Chávez-Fumagalli; Danielle F de Magalhães-Soares; Daniel Menezes-Souza; Bruno M Roatt; Ricardo A Machado-de-Ávila; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

3.  Evaluating complete surface-associated and secretory proteome of Leishmania donovani for discovering novel vaccines and diagnostic targets.

Authors:  Munawwar Karim; Garima Singh; Shweta Thakur; Aarti Rana; Abdur Rub; Yusuf Akhter
Journal:  Arch Microbiol       Date:  2022-09-07       Impact factor: 2.667

4.  Bioprospection and Selection of Peptides by Phage Display as Novel Epitope-Based Diagnostic Probes for Serological Detection of HTLV-1 and Use in Future Vaccines.

Authors:  Luiz Fernando Almeida Machado; Luiz Ricardo Goulart Filho; Fabiana Almeida Araújo Santos; Leonardo Quintão Siravenha; Andrea Nazaré Monteiro Rangel Silva; Maria Alice Freitas Queiroz; Antonio Carlos Rosário Vallinoto; Marluísa Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Front Med (Lausanne)       Date:  2022-06-09

5.  Improved serological detection of rheumatoid arthritis: a highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display.

Authors:  Galber Rodrigues Araujo; Emília Rezende Vaz; Patricia Tiemi Fujimura; João Eurico Fonseca; Lucélia Maria de Lima; Helena Canhão; Gabriela Venturini; Karina Helena Morais Cardozo; Valdemir Melechco Carvalho; Marcelo Henrique Napimoga; Luiz Ricardo Goulart; João Gonçalves; Carlos Ueira-Vieira
Journal:  Arthritis Res Ther       Date:  2015-06-23       Impact factor: 5.156

6.  Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.

Authors:  Lourena Emanuele Costa; Luiz Ricardo Goulart; Nathália Cristina de Jesus Pereira; Mayara Ingrid Sousa Lima; Mariana Costa Duarte; Vivian Tamietti Martins; Paula Sousa Lage; Daniel Menezes-Souza; Tatiana Gomes Ribeiro; Maria Norma Melo; Ana Paula Fernandes; Manuel Soto; Carlos Alberto Pereira Tavares; Miguel Angel Chávez-Fumagalli; Eduardo Antonio Ferraz Coelho
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

7.  Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection.

Authors:  Fernanda Fonseca Ramos; Lourena Emanuele Costa; Daniel Silva Dias; Thaís Teodoro Oliveira Santos; Marcella Rezende Rodrigues; Daniela Pagliara Lage; Beatriz Cristina Silveira Salles; Vívian Tamietti Martins; Patrícia Aparecida Fernandes Ribeiro; Miguel Angel Chávez-Fumagalli; Ana Carolina Silva Dias; Patrícia Terra Alves; Érica Leandro Marciano Vieira; Bruno Mendes Roatt; Daniel Menezes-Souza; Mariana Costa Duarte; Antonio Lúcio Teixeira; Luiz Ricardo Goulart; Eduardo Antonio Ferraz Coelho
Journal:  Parasit Vectors       Date:  2017-12-21       Impact factor: 3.876

8.  New antigens for the serological diagnosis of human visceral leishmaniasis identified by immunogenomic screening.

Authors:  Ana Maria Ravena Severino Carvalho; Tiago Antônio de Oliveira Mendes; Eduardo Antonio Ferraz Coelho; Mariana Costa Duarte; Daniel Menezes-Souza
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

Review 9.  Phage display as a promising approach for vaccine development.

Authors:  Leili Aghebati-Maleki; Babak Bakhshinejad; Behzad Baradaran; Morteza Motallebnezhad; Ali Aghebati-Maleki; Hamid Nickho; Mehdi Yousefi; Jafar Majidi
Journal:  J Biomed Sci       Date:  2016-09-29       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.